MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid® Distribution in Europe
Feedback from key opinion leaders and customers indicates that NexoBrid, a non-surgical solution for eschar removal in burns, is a perfect complement to PMI's existing product line, including SUPRATHEL®, NovoSorb® BTM, and SUPRA SDRM®.
- Feedback from key opinion leaders and customers indicates that NexoBrid, a non-surgical solution for eschar removal in burns, is a perfect complement to PMI's existing product line, including SUPRATHEL®, NovoSorb® BTM, and SUPRA SDRM®.
- Along with MediWound’s existing sales, marketing and medical teams’ infrastructure, PMI plans to leverage its extensive customer access and commercial resources to drive increased utilization of NexoBrid in the specified regions.
- “We are thrilled to establish this collaboration with PMI, bringing NexoBrid to a broader audience of burn surgeons and improving patients’ lives.
- “We are delighted to join forces with MediWound in this collaboration.